Leqvio (inclisiran) - Novartis
Praluent (alirocumab) - Sanofi, Regeneron
Repatha (evolocumab) - Amgen, Astellas
http://www.ncbi.nlm.nih.gov/pubmed/42141407
 
Dan Liu; Jiafang Yao; Junling Lin; Qiyin Sun; Wenjuan Wang
 
May 18, 2026
 
Prev Next